Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
Designing for Sustainability: Co-Designing and Testing the Efficacy of a Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety for Rural Older Cancer Survivors
5 other identifiers
interventional
578
1 country
1
Brief Summary
This clinical trial tests how well a web based toolkit works to improve cancer related emotional distress and anxiety in rural older cancer survivors. Rural older adults with cancer-related distress are particularly vulnerable to poorer mental health and cancer-related outcomes including increased difficulties identifying symptoms of anxiety, a reduced likelihood of knowing when to access mental health services, and a higher likelihood of having poorly managed CRD, even after receiving a psychosocial referral. The web based tool kit called CONNECT addresses digital literacy and supports for cancer-related distress management through interactive activities for setting up telehealth visits, accessing educational materials about cancer-related distress, and providing individualized mental health resource recommendations. Using CONNECT may improve cancer related emotional distress and anxiety in rural older cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 26, 2025
CompletedFirst Submitted
Initial submission to the registry
September 24, 2025
CompletedFirst Posted
Study publicly available on registry
December 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 26, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 26, 2032
December 18, 2025
December 1, 2025
6 years
September 24, 2025
December 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Cancer Related Distress (validated 23-item scale)
Cancer-related distress will be measured using the Cancer and Treatment Distress Scale (23 items; item scores 0-3; higher scores indicate greater distress). The CTXD assesses distress over the past week and includes six subscales: (1) uncertainty, (2) family strain, (3) health burden, (4) finances, (5) identity/appearance, and (6) medical demands. The primary outcome is the mean cumulative score across all items and subscales. A mean score above 0.85 indicates elevated distress in long-term survivors. The CTXD has demonstrated high validity and reliability across time, from pre-treatment to 18 years post-treatment, with Cronbach's alphas ranging from 0.77 to 0.90. The subscales align with the psychosocial domain identified in the NCCN Guidelines for Distress Management.
Up to 1 year
Secondary Outcomes (5)
Self-reported Healthcare Resource Usage
Up to 12 months
Self-reported Shared Device Use
Up to 12 months
Telehealth Utilization (self-reported use of portal, completed visits, and visit modality)
Up to 12 months
Cancer Survivors' Unmet Needs (validated 35-item scale)
Up to 12 months
Caregiver Strain Index (validated 13-item scale)
Up to 12 months
Study Arms (3)
Arm I (Advisory board)
EXPERIMENTALAdvisory board members complete small group workshops, interviews and surveys on study.
Arm II (CONNECT platform)
EXPERIMENTALPatients and their caregivers receive access to the CONNECT platform, which includes educational materials on distress management, guides to telehealth and personalized recommendations for resources. Patients and their caregivers complete a guided tutorial of the platform with a research assistant at the start of the intervention period, receive biweekly phone calls with the research assistant, for 20 minutes starting on 14 days to 2 months to review the four cancer-related management functions and receive a text message reminders to encourage use, every 2 weeks for 4 months.
Arm III (Educational brochure)
ACTIVE COMPARATORPatients are mailed an educational brochure about distress management on study.
Interventions
Receive educational materials on distress management and guides to telehealth
Complete interview
Receive personalized recommendations for resources
Ancillary study
Complete calls with research assistant
Receive text message reminders
Eligibility Criteria
You may qualify if:
- AIM 1: Invited by a member of the study team
- AIM 1: In the following or related field:
- Healthcare professionals (physicians, nurses, pharmacists, etc.)
- Patient advocates and representatives
- Researchers in healthcare or technology fields
- Healthcare administrators and managers
- AIM 1: Must be over 18 years old
- AIM 1: English-speaking
- AIM 1: Willing and able to provide informed consent
- AIM 2 (RURAL OLDER CANCER SURVIVORS): A rural resident based on the Health Resources \& Services Administration (HRSA) rural analyzer
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report of diagnosis with any cancer
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report posttreatment (i.e., completion of curative intent therapy including surgery, chemotherapy, molecularly targeted, and endocrine therapy)
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Have access to a computer, a smartphone, or a tablet computer
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Aged \> 65 years old
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Assessed as having Cancer and Treatment Distress scale (CTXD) scores \> 0.85 at screening
- +11 more criteria
You may not qualify if:
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Experience a cancer recurrence or a new cancer diagnosis during their participation in the trial because of the body of literature that reports increased distress associated with cancer recurrence
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Are inpatients
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Cognitive impairment precludes the ability to provide written consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- National Cancer Institute (NCI)collaborator
- National Institute of Nursing Research (NINR)collaborator
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marquita W Lewis, PhD
Northwestern University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Study staff abstracting the data will be blinded to the participant's condition.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2025
First Posted
December 18, 2025
Study Start
August 26, 2025
Primary Completion (Estimated)
August 26, 2031
Study Completion (Estimated)
August 26, 2032
Last Updated
December 18, 2025
Record last verified: 2025-12